Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
Author:
Funder
UGC DAE Consortium for Scientific Research
Publisher
Elsevier BV
Subject
Analytical Chemistry,Electrochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Pharmacy
Reference129 articles.
1. A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer;Malla;Biophys. Rev.,2019
2. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge;Nedeljković;Cells,2019
3. Study on the mechanism of cell cycle checkpoint Kinase 2 (CHEK2) gene dysfunction in chemotherapeutic drug resistance of triple negative breast cancer cells;Luo;Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.,2018
4. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer;Shu;Nature,2016
5. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells;Mani;Breast Cancer Res.,2019
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Garlic‐derived compounds: Epigenetic modulators and their antitumor effects;Phytotherapy Research;2024-01-09
2. Enhanced Electrochemical Characterization of the Immune Checkpoint Protein PD‐L1 using Aptamer‐Functionalized Magnetic Metal‐Organic Frameworks;Advanced Healthcare Materials;2024-01-02
3. Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPARγ/NF-κB pathway;Food & Function;2024
4. Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells;Annals of Hematology;2023-12-27
5. Current Perspectives and Trend of Acupuncture in Breast Cancer-Related Symptoms: A Bibliometric Study;Journal of Pain Research;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3